Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06544616
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
A Study of JNJ-64042056 in Participants With Preclinical Alzheimers Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Randomized Placebo-Controlled Double-Blind Parallel-Group Study to Assess Efficacy Safety and Immunogenicity of JNJ-64042056 a Phosphorylated Tau Targeted Active Immunotherapy in Participants With Preclinical Alzheimers Disease
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Reτain
Brief Summary:
The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline as measured by Preclinical Alzheimers disease Cognitive Composite 5 PACC-5 compared with placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None